<DOC>
	<DOCNO>NCT00358228</DOCNO>
	<brief_summary>The primary study objective ass efficacy 2 fixed dos rimonabant versus placebo abstinence tobacco use cigarette smoker . The secondary study objective : - To evaluate effect rimonabant crave weight ; - To evaluate clinical biological safety tolerability rimonabant population cigarette tobacco smoker 10-week treatment period - To evaluate population pharmacokinetics rimonabant ( ie , standard PK evaluation population smoker ) ; - To observe percentage abstinent patient 40-week follow-up post treatment period ; - To evaluate quality life ( QOL ) pharmacoeconomics .</brief_summary>
	<brief_title>Comparison Efficacy Safety 2 Oral Doses Rimonabant , 5 mg/Day 20 mg/Day , Versus Placebo , Aid Smoking Cessation ( STRATUS US )</brief_title>
	<detailed_description />
	<mesh_term>Rimonabant</mesh_term>
	<criteria>Smokers smoke least 10 cigarettes/day ( average ) 2 month precede screen visit ; Motivated quit smoking ( Motivation Scale Score equal 6 10point scale ) . Smoked consume 3 time within 3 month immediately precede screen visit : non tobacco cigarette related product form tobacco product cigarettes ; Current regular consumption marijuana ( hashish ) . Met current criterion MINI International Neuropsychiatric Interview ( MINI ) follow psychiatric disorders/states : major depressive episode , dysthymia , suicidality , manic episode hypomanic episode , panic disorder , agoraphobia , social phobia ( social anxiety disorder ) , obsessive compulsive disorder , posttraumatic stress disorder , alcohol dependence abuse , substance dependence abuse ( exclude nicotine caffeine ) , anorexia nervosa , bulimia nervosa , generalize anxiety disorder ; Met lifetime criterion MINI manic episode hypomanic episode , psychotic disorder ; Carried diagnosis , suspicion cognitive disorder ( eg , delirium , dementia , amnestic disorder ) psychiatric developmental disorder define Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMIV ) may interfere his/her ability understand complete study related procedure ; Had history severe depression , ie , require hospitalization , patient 2 recurrent episode depression , history multiple suicide attempt ; Had use , within 3 month screen visit : Nicotine replacement type 3 day maximum prescribed dose , Behavioral and/or motivational counseling , therapy , support group , procedure intend assist smoking cessation 3 day , Bupropion ( amphebutamone ) , Systemic long act corticosteroid , Any therapy intend treat alleviate depressive symptom ( pharmacologic , somatic , psychological ) 1 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Smoking cessation</keyword>
	<keyword>Abstinence</keyword>
</DOC>